The DOI matches its Crossref record, with a small difference in title or year; 34 of the 35 references it cites were found in a registry or an index; 12 of the 53 sources its claims cite were checked for support.
“I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design)
Open accessAbstract
The misuse of substances is often maintained by both physical and psychological factors. Opioid-substitution medications manage physical aspects of addiction; however, difficulties with emotional regulation and avoidance perpetuate continued substance misuse. In the UK, individuals who misuse substances are often excluded from mental health services, meaning these underlying difficulties are not addressed. Acceptance and Commitment Therapy (ACT) seeks to reduce emotional avoidance. A hermeneutic single-case efficacy design was used to evaluate the effects of ACT within drugs and alcohol service. Quantitative and qualitative data was critically analysed to understand factors involved in identified changes. Analysis recognised the client progressed towards two of three of their goals, related to motivation and anxiety. Their psychological flexibility also increased. ACT processes played a key role in this; however, the therapeutic relationship and psychopharmacological factors were also noted. Study limitations and clinical and research implications are discussed. © 2021, The Author(s).
Overview
CoChat Summary
## TL;DR
This hermeneutic single-case efficacy study examined ACT for one client, “Bruce,” who was struggling to reduce low-dose buprenorphine in a UK drugs and alcohol service. The paper concludes Bruce showed personally meaningful improvements in motivation, coping with difficulties, and psychological flexibility, but that relational and psychopharmacological factors may also have contributed.
## Key findings
- Bruce completed 12 weekly 45-minute ACT sessions; quantitative analysis found reliable change (RC) on all scales except PQ goal 2, and clinically significant change (CSC) for PQ goals 1 and 3, overall psychological flexibility (CompACT-8 total), and VA.
- The paper states Bruce experienced three meaningful changes: increased motivation and engagement in meaningful activities, increased ability to cope with difficult experiences, and increased psychological flexibility.
- Bruce’s self-identified PQ goals were motivation, housing situation, and anxiety/social anxiety; the paper reports CSC for motivation and social anxiety, but not for the housing goal.
- Buprenorphine dosage increased from 0.4 mg daily to 0.8 mg daily during therapy; the paper says no follow-up dosage data were available because of COVID-19-related service changes.
## Methods
- Design: Hermeneutic single-case efficacy design (HSCED), using an affirmative vs. sceptical case comparison with triangulation of quantitative and qualitative evidence.
- Sample/data: One accessible case (“Bruce”), drawn from 8 service-identified individuals offered ACT; 2 completed ACT, but only 1 case was available for analysis due to COVID-19. Bruce attended 12 weekly 45-minute sessions.
- Analysis: Weekly psychometrics (PQ, SRS, CompACT-8, and SWEMWBS at first/last session), buprenorphine dose monitoring, clinical notes, and a post-therapy change interview were analyzed using reliable change, clinical significance, visual trend analysis, and HSCED adjudication.
## Limitations
- The paper states that no extended baseline was established for any measure because withholding treatment was considered ethically problematic.
- The paper states there was no follow-up data, so it could not assess whether the changes were lasting.
- The paper notes limitations with the outcome measures: Bruce’s housing goal may have been unachievable or inappropriate as an ACT outcome, and his wellbeing score may have shown a ceiling effect because it was already above the non-clinical population mean.
- Evident from the text: this is a single case, so the findings are not directly generalizable beyond Bruce; also, the paper notes fidelity monitoring relied on therapist self-report, and independent critique was unavailable, both of which limit certainty.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
10 Valid · 2 Not valid · 28 Not checked · 111 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Opioid-substitution medications manage physical aspects of addiction; however, difficulties with emotional regulation and avoidance perpetuate continued substance misuse.”
- Also stated in: § Abstract · hedged
“increasing evidence suggests many individuals use substances primarily to regulate or avoid painful emotions (Weiss et al., 2014).”
§ “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design) > Abstract
What the sources say
- Partly supportedcites Weiss et al., 2014 sourceExperimental — accuracy not yet measured
The Results (page unavailable) report an association between avoidance coping and drug-use problems among women exposed to intimate partner violence, but it is U-shaped: moderate avoidance was associated with the fewest problems. The Discussion (page unavailable) says the cross-sectional data cannot establish whether avoidance perpetuates drug use. The study did not establish that difficulties with emotional regulation perpetuate misuse. (LLM, conf=0.89)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · hedged
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Opioid-substitution medications manage physical aspects of addiction; however, difficulties with emotional regulation and avoidance perpetuate continued substance misuse.”
§ “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design) > Abstract
What the sources say
- Supportedcites Johnson et al., 2005 source
The Introduction states that sublingual buprenorphine is approved to treat opioid addiction. The Physical Dependence Liability section reports that buprenorphine substituted for morphine and suppressed withdrawal, supporting the claim that substitution medication can manage a physical aspect of addiction. The sentence’s separate point about emotional regulation is not part of the claim attributed to this source. (LLM, conf=0.84)
- Not matchedcites Joint Formulary Committee, 2020
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Aspects of ACT, such as reducing avoidance and increasing present moment awareness, have been found to effectively reduce substance use via improving emotional regulation (Conklin et al., 2015; Tang et al., 2016).”
§ “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design) > ACT and Substance Dependency Treatments
What the sources say
- Partly supportedcites Conklin et al., 2015 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that reduced maladaptive emotion-regulation strategy use was associated with reduced symptom severity during treatment of people with comorbid alcohol use and anxiety disorders. It does not establish that ACT techniques—specifically reduced avoidance or increased present-moment awareness—reduced substance use through improved emotion regulation: participants received cognitive-behavioral therapy or progressive muscle relaxation, and the authors caution that their pre/post measurements cannot establish which change came first. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites Tang et al., 2016 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, once emotional regulation and avoidance are addressed via psychological therapy, substance use and mental health conditions improve (Bahrami & Asghari, 2017; Conklin et al., 2015; Twohig et al., 2007).”
§ “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design) > Abstract
What the sources say
- Not checked — no full text of the sourcecites Bahrami & Asghari, 2017 source
- Partly supportedcites Conklin et al., 2015 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that reductions in maladaptive emotion-regulation strategies during treatment were associated with reductions in psychopathology among patients with comorbid alcohol-use and anxiety disorders. The claim overstates this association as a treatment-driven improvement: the authors say their pre/post measurements cannot establish whether strategy changes preceded symptom changes. The paper also does not establish that addressing avoidance specifically improved both substance use and mental health outcomes. (LLM, conf=0.87)
- Partly supportedcites Twohig et al., 2007 sourceExperimental — accuracy not yet measured
The Results (page unavailable) report reduced marijuana use after acceptance and commitment therapy, which addressed avoidance of difficult thoughts and feelings. The Discussion reports lower average anxiety and depression scores, but individual results were inconsistent and co-occurring mental health conditions were not formally assessed. The three-person preliminary study therefore does not establish the broader claim that addressing emotional regulation and avoidance improves both substance use and mental health conditions. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ACT has been found to increase the effectiveness of opioid-substitute medications for polysubstance misuse compared to medications or other psychological therapies used alone (Hayes et al., 2004).”
§ “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design) > ACT and Substance Dependency Treatments
What the sources say
- Partly supportedcites Hayes et al., 2004 sourceExperimental — accuracy not yet measured
The Discussion (p. 15) says ACT may add to the benefits of methadone maintenance, and the ACT Versus MM Alone results (p. 13) report lower drug use at follow-up. But this preliminary trial did not compare ACT plus medication with psychological therapy used alone; its direct comparison with twelve-step facilitation plus methadone was underpowered (Analytic Approach, p. 9). The claim also generalizes from methadone to opioid-substitute medications more broadly. (LLM, conf=0.89)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
38 more claims
Create a free account to see all 151 claims and every source verdict.
- Probably not a substantial claim. 57
- It may state two separate claims as one. 73
Citations
Cites
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770 · cited 2×
“Reliable change (RC) computations were applied to examine the statistical reliability of quantitative changes (Jacobson & Truax, 1991).”
MethodThe Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation
Tennant, R., Hiller, L., Fishwick, R., Platt, S., Joseph, S., Weich, S., Parkinson, J., Secker, J., & Stewart-Brown, S. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-63 · Cited by 5,031
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785 · cited 1×
“Understanding drug addiction via biological mechanisms alone, however, is reductionist, considering many individuals continue to take substances in the absence of withdrawal symptoms or craving (Everitt & Robbins, 2005).”
BackgroundStewart-Brown, S., Tennant, A., Tennant, R., Platt, S., Parkinson, J., & Weich, S. (2009) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-7-15 · Cited by 1,251
Premature discontinuation in adult psychotherapy: A meta-analysis
Swift, J. K., & Greenberg, R. P. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0028226 · Cited by 978 · cited 1×
“Importantly, it is expected that around 20% of individuals will terminate psychotherapy early regardless of modality (Swift & Greenberg, 2012).”
BackgroundAcceptance and Commitment Therapy as a Unified Model of Behavior Change
Hayes, S. C., Pistorello, J., & Levin, M. E. (2012) · The Counseling Psychologist · doi:10.1177/0011000012460836 · Cited by 718 · cited 1×
“Processes are only considered pathological, however, if they are maladaptive or problematic for the individual (Hayes et al., 2012).”
Background(2009) · Cited by 655
Ng Fat, L., Scholes, S., Boniface, S., Mindell, J., & Stewart-Brown, S. (2017) · Quality of Life Research · doi:10.1007/s11136-016-1454-8 · Cited by 548
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
Sees, K. L., Delucchi, K. L., Masson, C., Rosen, A., Clark, H. W., Robillard, H., Banys, P., & Hall, S. M. (2000) · JAMA · doi:10.1001/jama.283.10.1303 · Cited by 415 · cited 1×
“Consequently, maintenance therapies are considered “successful” due to their association with reduced illicit drug use (Sees et al., 2000).”
Background
Research works printed but not linked: 2
- Duncan, B. L., Miller, S. D., Sparks, J. A., Claud, D. A., Reynolds, L. R., Brown, J., et al. (2003). the session rating scale: Preliminary psychometric properties of a “working” alliance measure. Journal of Brief Therapy, 3(1), 3–12.
- Public Health England. (2017). Better care for people with co-occurring mental health and alcohol/drug use conditions. Public Health England.
Cited by
Moghaddam, N. G., Morris, J. L., Bayliss, K., & Dawson, D. L. (2023) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2023.06.003 · Cited by 23
Self-citationSulistiyowati, L., Keliat, B. A., & Hargiatna, G. (2023) · Jurnal Keperawatan Silampari · doi:10.31539/jks.v6i2.5737
Buckley, S., Tickle, A., Eagle, R., & Dawson, D. L. (2024) · International Journal on Homelessness · doi:10.5206/ijoh.2023.3.15102 · Cited by 2
Self-citation
Metadata
- Authors
- Shepherd, K., Pritty, B., Tickle, A., & Moghaddam, N.
- Affiliations
- University of Lincoln (GB)
- University of Nottingham (GB)
- Corresponding author
- Tickle, Anna
- Venue
- International Journal of Mental Health and Addiction
- Published
- 2021-12-20
- Volume
- 21
- Issue
- 4
- Pages
- 2418-2441
- ISSN
- 1557-1874 (ISSN-L)
- 1557-1882
- PMC
- PMC8686789
- OpenAlex
- W4200217104
- Cited by
- 6
- References
- 35
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 1
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- International Journal of Mental Health and Addiction (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (publishedVersion, other-oa)
- Lincoln Repository (University of Lincoln) (acceptedVersion)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- acceptance and commitment therapy, buprenorphine, opioid substitution therapy, opioid misuse, substance abuse, emotional avoidance, psychological flexibility, motivation, anxiety, therapeutic relationship, psychopharmacology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design). https://app.cochat.ai/papers/10.1007/s11469-021-00729-2
- The paper
- Shepherd, K., Pritty, B., Tickle, A., & Moghaddam, N. (2023). “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design). International Journal of Mental Health and Addiction. https://doi.org/10.1007/s11469-021-00729-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.